ANXA8 and gastric cancer: Meanwhile, ANXA8 overexpression in gastric cancer has been correlated with disease stage and differentiation grading, and it emerged as an independent predictor of worse OS and DFS and a potential poor prognosis biomarker for gastric cancer patients (Ma et al., 2020).